<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03259204</url>
  </required_header>
  <id_info>
    <org_study_id>2017-00202</org_study_id>
    <nct_id>NCT03259204</nct_id>
  </id_info>
  <brief_title>Swedish Multicenter Trial of Outpatient Prevention of Leg Clots</brief_title>
  <acronym>StopLegClots</acronym>
  <official_title>Prevention of Thromboembolism and Failed Healing During Lower Limb Immobilization - Multicenter Study With Adjuvant Intermittent Pneumatic Compression Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danderyd Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stockholm South General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Uppsala University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Visby lasarett</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gävle Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Höglandssjukhuset Eksjö</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norrtälje Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lower limb immobilization is associated with high risk of complications, i.e. venous
      thromboembolism (VTE) and failed healing. Pharmacoprophylaxis of VTE is in leg-immobilized
      patients, however, low- or non-effective and associated with adverse events. Thus, there is a
      need for novel treatments.

      This study aims to demonstrate in leg immobilized patients who have suffered an ankle
      fracture (1000 patients) or an Achilles tendon rupture (400 patients) that adjuvant
      intermittent pneumatic compression (IPC) therapy, which targets impaired vascular flow,
      compared to treatment-as-usual with plaster cast, reduces VTE incidence and improves healing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed intervention, intermittent pneumatic compression (IPC) is an evidence-based
      prevention for VTE in hospitalized patients and used in daily practice. IPC is, however, not
      currently used on outpatients and it is currently unknown if it reduces the risk of VTE
      during long term leg-immobilization. Plaster cast and orthosis treatments are currently used
      in daily practice on Achilles tendon ruptures and ankle fractures. At present there is no
      consensus about using VTE prophylaxis in leg-immobilized patients. Since pharmacoprophylaxis
      has shown low- or no VTE preventive effects in leg-immobilization, is not recommended by some
      guidelines.

      Furthermore, since all patients will undergo clinical examinations and have DVT-screening
      performed with compression Doppler ultrasound (CDU) removal of leg immobilization this will
      comprise an extra security for the included patients to detect a VTE. If a VTE is detected
      clinical guidelines will be followed by initiating chemical VTE-treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 21, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Venous Thromboembolic Events (VTE)</measure>
    <time_frame>Up til the time of removal of leg immobilization, approx. 6-8 weeks</time_frame>
    <description>The primary outcome is VTE defined as symptomatic Deep venous Thrombosis (DVT) or asymptomatic DVTs,or symptomatic pulmonary embolism</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient reported Outcome - ATRS</measure>
    <time_frame>6 months and 1 year</time_frame>
    <description>symptoms will be assessed using the reliable and valid score; the Achilles tendon Total Rupture Score (ATRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported Outcome - FAOS</measure>
    <time_frame>6 months and 1 year</time_frame>
    <description>symptoms will be assessed using the reliable and valid score; the Foot and Ankle Outcome Score (FAOS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported Outcome - OMAS</measure>
    <time_frame>6 months and 1 year</time_frame>
    <description>symptoms will be assessed using the reliable and valid score; the Olerud-Molander Ankle Score (OMAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported Outcome - EQ-5D-5L</measure>
    <time_frame>6 months and 1 year</time_frame>
    <description>symptoms will be assessed using the reliable and valid score; EuroQol Group's questionnaire (EQ-5D-5L).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome - muscular endurance tests (heel-rise)</measure>
    <time_frame>1 year</time_frame>
    <description>Patient leg function will be measured by a validated endurance test (i.e. the heel-rise test) at 1 year post-injury.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Callus production</measure>
    <time_frame>6 weeks</time_frame>
    <description>Microdialysis followed by quantification of procollagens will assess callus production in Achilles tendon healing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VTE-preventive mechanisms</measure>
    <time_frame>6 weeks</time_frame>
    <description>VTE-preventive mechanisms will be analyzed at the 6 week visit by assessments of profibrinolysis and coagulation factors as well as by blood-flow quantification .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of VTE in patients using low molecular weight heparin(LMWH) with or without adjvant IPC</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>Efficiancy of LMWH with and without the use of IPC as to prevent VTE will be studied in order to confirm the efficency of a commonly used drug for VTE prophylaxis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1400</enrollment>
  <condition>Achilles Tendon Rupture</condition>
  <condition>Ankle Fractures</condition>
  <condition>Venous Thromboembolism</condition>
  <arm_group>
    <arm_group_label>Leg Immobilization</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Routine care include that the lower limb will be immobilized in an orthosis or a below-knee plaster cast according to local routines.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adjuvant IPC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Leg Immobilization with the addition of IPC. Patients will during lower limb immobilization receive bilateral calf IPC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Adjuvant IPC</intervention_name>
    <description>This IPC-system delivers sequential circumferential compression. The IPC device is mobile and should therefore not restrict patient mobilization, but can be taken off if the patient wants to mobilize independently.</description>
    <arm_group_label>Adjuvant IPC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute unilateral Achilles tendon rupture or isolated Ankle Fracture

          -  Treatment starts within 10 days in a hospital setting

        Exclusion Criteria:

          -  Inability or refusal to give informed consent for participation in the study

          -  Inability to comply with the study instructions

          -  Known kidney disorder

          -  Heart failure with pitting oedema

          -  Presence of known malignancy

          -  Current bleeding disorder

          -  Pregnancy

          -  Planned follow-up at another hospital

          -  Pilon fracture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul W Ackermann, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital, 171 76 Stockholm, SWEDEN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luigi Belcastro, RN</last_name>
    <phone>+46851775678</phone>
    <email>luigi.belcastro@sll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Simon Svedman, MD</last_name>
    <email>Simon.svedman@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Svedman, MD</last_name>
      <phone>+46765930550</phone>
      <email>Simon.svedman@ki.se</email>
    </contact>
    <contact_backup>
      <last_name>Luigi Belcastro, RN</last_name>
      <phone>+46736994845</phone>
      <email>luigi.belcastro@sll.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://ki.se/mmk/stop-leg-clots</url>
    <description>Official study site</description>
  </link>
  <reference>
    <citation>Arverud ED, Anundsson P, Hardell E, Barreng G, Edman G, Latifi A, Labruto F, Ackermann PW. Ageing, deep vein thrombosis and male gender predict poor outcome after acute Achilles tendon rupture. Bone Joint J. 2016 Dec;98-B(12):1635-1641.</citation>
    <PMID>27909125</PMID>
  </reference>
  <reference>
    <citation>Domeij-Arverud E, Ackermann PW. Deep Venous Thrombosis and Tendon Healing. Adv Exp Med Biol. 2016;920:221-8. doi: 10.1007/978-3-319-33943-6_21. Review.</citation>
    <PMID>27535264</PMID>
  </reference>
  <reference>
    <citation>Domeij-Arverud E, Labruto F, Latifi A, Nilsson G, Edman G, Ackermann PW. Intermittent pneumatic compression reduces the risk of deep vein thrombosis during post-operative lower limb immobilisation: a prospective randomised trial of acute ruptures of the Achilles tendon. Bone Joint J. 2015 May;97-B(5):675-80. doi: 10.1302/0301-620X.97B5.34581.</citation>
    <PMID>25922463</PMID>
  </reference>
  <reference>
    <citation>Abdul Alim M, Domeij-Arverud E, Nilsson G, Edman G, Ackermann PW. Achilles tendon rupture healing is enhanced by intermittent pneumatic compression upregulating collagen type I synthesis. Knee Surg Sports Traumatol Arthrosc. 2017 Jul 1. doi: 10.1007/s00167-017-4621-8. [Epub ahead of print]</citation>
    <PMID>28668970</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2017</study_first_submitted>
  <study_first_submitted_qc>August 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Paul Ackermann</investigator_full_name>
    <investigator_title>Senior lecturer, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Achilles tendon</keyword>
  <keyword>Microdialysis</keyword>
  <keyword>Immobilization</keyword>
  <keyword>Wound healing</keyword>
  <keyword>Intermittent Pneumatic Compression</keyword>
  <keyword>Ultrasonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
    <mesh_term>Rupture</mesh_term>
    <mesh_term>Ankle Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

